EUVIMEDEUVIMED entdecken
VergleichsstudieKohortenstudie

Do myomectomies alter third‐trimester complications compared with women without myomectomies and uterine fibroids in situ: A retrospective cohort study of an American population database

Perrine Ginod iD, Ahmad Badeghiesh, Haitham Baghlaf, Michael H Dahan

International Journal of Gynecology & Obstetrics · 2025

DOI: 10.1002/ijgo.70211 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift International Journal of Gynecology & Obstetrics, 2025. Verfasst von Perrine Ginod und 3 weiteren Autor:innen. Beteiligte Einrichtung: MUHC Reproductive Centre, McGill University, Montréal, Quebec, Canada. Hauptthemen laut MEDLINE: Uterine Myomectomy, Leiomyoma, Uterine Neoplasms, Pregnancy Complications. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate population characteristics and pregnancy, delivery, and neonatal complications in women with myomectomy prior to pregnancy versus intramural fibroids in situ.

Methods

Retrospective cohort study using hospital discharge data from the Healthcare Cost and Utilization Project Nationwide Inpatient Sample from 2004 to 2014 included. A population of 14 206 pregnancies post‐myomectomy and 81 517 with fibroids in situ were analyzed, performing multivariate logistic regression with adjustment.

Results

Post‐myomectomy patients were younger, with lower body mass index, higher in vitro fertilization use, more commonly Caucasians or Hispanics, and had higher rates of pregestational diabetes, smoking, illicit drug use, previous cesarean delivery, and multiple gestations, compared with the in‐situ fibroid (ISF) group. Post‐myomectomy patients had decreased rates of gestational hypertension (adjusted odds ratio [aOR] 0.87, 95% confidence interval [CI] 0.77–0.97), eclampsia (aOR 0.76, 95% CI 0.32–0.81), gestational diabetes (aOR 0.83, 95% CI 0.77–0.90), spontaneous vaginal deliveries (aOR 0.09, 95% CI 0.08–0.11), postpartum hemorrhage (aOR 0.77, 95% CI 0.68–0.88), and intrauterine fetal death (aOR 0.64, 95% CI 0.43–0.97). Conversely, they had increased risks of placenta previa (aOR 1.40, 95% CI 1.20–1.64), preterm delivery (aOR 1.16, 95% CI 1.07–1.24), cesarean section (aOR 8.64, 95% CI 7.71–9.69), uterine rupture (aOR 2.21, 95% CI 1.31–3.74), transfusions (aOR 1.79, 95% CI 1.59–2.02), and congenital anomalies (aOR 2.35, 95% CI 2.01–2.75).

Conclusions

The ISF group experienced different complications than the post‐myomectomy group. Pregnancies post‐myomectomy could benefit from additional screening or interventions during pregnancy to reduce complications from malplacentation and ensure delivery in specialized centers to mitigate risks. Patients should be counseled regarding these potential risks. Increased understanding of the role of myomectomies on reproductive outcomes requires further prospective studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine MyomectomyLeiomyomaUterine NeoplasmsPregnancy ComplicationsPregnancy Complications, NeoplasticHumansFemalePregnancyRetrospective StudiesAdultUnited StatesDatabases, FactualDiabetes, GestationalPregnancy OutcomeCesarean SectionYoung AdultInfant, NewbornCohort StudiesLogistic Models

Stichwörter der Autor:innen

hypertensive disorders of pregnancyobstetrical complicationsplacenta previauntreated fibroidsuterine rupture

Autor:innen und Institutionen

  • MUHC Reproductive Centre, McGill University, Montréal, Quebec, Canada.
  • CHU Dijon Bourgogne, Service de Gynécologie-Obstétrique et Assistance Médicale à la Procréation, Dijon, France.
  • Division of Gynecology and Obstetrics, King Abdulaziz University, Rabigh Branch, Rabigh, Saudi Arabia.
  • Department of Obstetrics and Gynecology, University of Tabuk, Tabuk, Saudi Arabia.
  • Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, McGill University, Montréal, Quebec, Canada.

ORCID-Profile: Perrine Ginod

Zitieren

APA

Ginod, P., Badeghiesh, A., Baghlaf, H., & Dahan, M. H. (2025). Do myomectomies alter third‐trimester complications compared with women without myomectomies and uterine fibroids in situ: A retrospective cohort study of an American population database. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.70211

Vancouver

Ginod P, Badeghiesh A, Baghlaf H, Dahan MH. Do myomectomies alter third‐trimester complications compared with women without myomectomies and uterine fibroids in situ: A retrospective cohort study of an American population database. International Journal of Gynecology & Obstetrics. 2025. doi:10.1002/ijgo.70211

BibTeX
@article{Ginod2025,
  author = {Ginod, Perrine and Badeghiesh, Ahmad and Baghlaf, Haitham and Dahan, Michael H},
  title = {Do myomectomies alter third‐trimester complications compared with women without myomectomies and uterine fibroids in situ: A retrospective cohort study of an American population database},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2025},
  doi = {10.1002/ijgo.70211}
}
Kostenlos starten →